• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长激素缺乏症的垂体功能减退症患者的血清脂肪因子和低密度脂蛋白亚组分谱。

Serum adipokines and low density lipoprotein subfraction profile in hypopituitary patients with growth hormone deficiency.

机构信息

Division of Endocrinology and Metabolism, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Millet Cad., Capa-Istanbul, 34390, Turkey.

出版信息

Pituitary. 2012 Sep;15(3):386-92. doi: 10.1007/s11102-011-0332-1.

DOI:10.1007/s11102-011-0332-1
PMID:21833617
Abstract

The aim was to evaluate the concentrations of lipid subfractions in relation to adipokines and metabolic parameters in adult growth hormone (GH)-deficient hypopituitary patients on conventional replacement therapy. The study included 21 GH deficient-hypopituitary patients (age: 36.0 ± 15.1 years, male/female: 7/14) on conventional replacement therapy other than GH and 20 comparable controls (age: 37.3 ± 14.0 years, male/female: 6/14). Lipid subfractions (Lipoprint system), serum adipokine (leptin, adiponectin, resistin) concentrations, body composition, a surrogate marker for insulin resistance (HOMA) and conventional lipid profile were evaluated. No statistically significant difference was found with respect to HOMA, adipokine concentrations and anthropometric parameters between patients and controls except for significantly increased waist-to-hip ratio in hypopituitary group. Total and LDL cholesterol concentrations were significantly higher in the patients. LDL particle size (268.88 ± 3.16 vs. 271.31 ± 3.11 Å, P = 0.151) and small-dense LDL subfraction did not differ significantly. According to logistic regression analysis, triglyceride concentrations ≥1.69 mmol/L was the sole parameter significantly and independently predicted small (<268 Å) LDL particle size (P = 0.019) in the whole group. Increased triglyceride concentrations affect LDL particle size in GH-deficient hypopituitary patients. Small dense LDL seems not directly contribute to atherogenic potential in hypopituitarism.

摘要

目的在于评估脂类亚组分浓度与成人生长激素(GH)缺乏性垂体功能减退症患者的脂肪因子和代谢参数之间的关系。该研究纳入了 21 名正在接受除 GH 以外的常规替代疗法的 GH 缺乏性垂体功能减退症患者(年龄:36.0±15.1 岁,男/女:7/14)和 20 名可比对照组(年龄:37.3±14.0 岁,男/女:6/14)。评估了脂类亚组分(Lipoprint 系统)、血清脂肪因子(瘦素、脂联素、抵抗素)浓度、身体成分、胰岛素抵抗的替代标志物(HOMA)和常规血脂谱。除了垂体功能减退组的腰围/臀围比显著增加外,患者和对照组之间在 HOMA、脂肪因子浓度和人体测量参数方面没有统计学上的显著差异。患者的总胆固醇和 LDL 胆固醇浓度显著升高。LDL 颗粒大小(268.88±3.16 对 271.31±3.11 Å,P=0.151)和小而密 LDL 亚组分没有显著差异。根据逻辑回归分析,甘油三酯浓度≥1.69 mmol/L 是唯一显著且独立地预测整个组中 LDL 颗粒大小小(<268 Å)的参数(P=0.019)。升高的甘油三酯浓度会影响 GH 缺乏性垂体功能减退症患者的 LDL 颗粒大小。小而密的 LDL 似乎不会直接导致垂体功能减退症的动脉粥样硬化潜力增加。

相似文献

1
Serum adipokines and low density lipoprotein subfraction profile in hypopituitary patients with growth hormone deficiency.生长激素缺乏症的垂体功能减退症患者的血清脂肪因子和低密度脂蛋白亚组分谱。
Pituitary. 2012 Sep;15(3):386-92. doi: 10.1007/s11102-011-0332-1.
2
Elevated leptin concentrations in growth hormone-deficient hypopituitary adults.生长激素缺乏的垂体功能减退成年人体内瘦素浓度升高。
Clin Endocrinol (Oxf). 1997 Aug;47(2):153-9. doi: 10.1046/j.1365-2265.1997.2131054.x.
3
Serum lipid and leptin concentrations in hypopituitary patients with growth hormone deficiency.生长激素缺乏的垂体功能减退患者的血清脂质和瘦素浓度
Int J Obes Relat Metab Disord. 2000 May;24(5):619-26. doi: 10.1038/sj.ijo.0801206.
4
Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy.接受传统替代疗法的垂体功能减退女性的空腹和餐后血脂异常。
J Clin Endocrinol Metab. 1997 Aug;82(8):2653-9. doi: 10.1210/jcem.82.8.4129.
5
Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.低剂量滴定生长激素替代疗法对成年垂体功能减退患者循环胆固醇的持续降低作用:一项为期两年的研究
Clin Endocrinol (Oxf). 2000 Oct;53(4):453-9. doi: 10.1046/j.1365-2265.2000.01108.x.
6
Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy.生长激素(GH)替代治疗可降低接受维持性HMG CoA还原酶抑制剂(他汀类药物)治疗的垂体功能减退患者的血清总胆固醇和低密度脂蛋白胆固醇水平。
Clin Endocrinol (Oxf). 2007 Oct;67(4):623-8. doi: 10.1111/j.1365-2265.2007.02935.x. Epub 2007 Jun 20.
7
Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy.接受传统激素替代疗法的垂体功能减退成年人的低密度脂蛋白颗粒大小
J Clin Endocrinol Metab. 1996 Jul;81(7):2448-54. doi: 10.1210/jcem.81.7.8675559.
8
Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.老年垂体功能减退成人的生长激素缺乏与替代治疗。KIMS研究组及KIMS国际委员会。法玛西亚和普强国际代谢数据库。
Clin Endocrinol (Oxf). 2000 Sep;53(3):281-9. doi: 10.1046/j.1365-2265.2000.01104.x.
9
Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.生长激素缺乏患者短期替代治疗前后的致动脉粥样硬化脂蛋白表型及低密度脂蛋白大小和亚类
Eur J Endocrinol. 2007 Mar;156(3):361-7. doi: 10.1530/EJE-06-0652.
10
Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.2589例垂体功能减退性生长激素缺乏成人患者心血管风险的决定因素——一项KIMS数据库分析
Eur J Endocrinol. 2006 Jul;155(1):79-90. doi: 10.1530/eje.1.02179.

引用本文的文献

1
Effects of adult growth hormone deficiency and replacement therapy on the cardiometabolic risk profile.成年人生长激素缺乏症及替代疗法对心血代谢风险特征的影响。
Pituitary. 2022 Apr;25(2):211-228. doi: 10.1007/s11102-022-01207-1. Epub 2022 Feb 1.
2
A Functional Interplay between IGF-1 and Adiponectin.胰岛素样生长因子 1(IGF-1)与脂联素的功能相互作用。
Int J Mol Sci. 2017 Oct 14;18(10):2145. doi: 10.3390/ijms18102145.
3
Short-term efficacy of recombinant human GH therapy in cured acromegaly patients with GH deficiency: a single-center experience.

本文引用的文献

1
Adipokines and insulin resistance.脂肪因子与胰岛素抵抗。
Mol Med. 2008 Nov-Dec;14(11-12):741-51. doi: 10.2119/2008-00058.Rabe. Epub 2008 Sep 17.
2
Effects of GH treatment in GH-deficient adults on adiponectin, leptin and pregnancy-associated plasma protein-A.生长激素治疗对生长激素缺乏的成年人脂联素、瘦素和妊娠相关血浆蛋白A的影响。
Eur J Endocrinol. 2008 Apr;158(4):483-90. doi: 10.1530/EJE-07-0554.
3
Adipokine protein expression pattern in growth hormone deficiency predisposes to the increased fat cell size and the whole body metabolic derangements.
cured 肢端肥大症患者生长激素缺乏时重组人生长激素治疗的短期疗效:单中心经验。
Endocr Connect. 2015 Mar;4(1):65-75. doi: 10.1530/EC-14-0132. Epub 2015 Jan 19.
生长激素缺乏症中的脂肪因子蛋白表达模式易导致脂肪细胞大小增加和全身代谢紊乱。
J Clin Endocrinol Metab. 2008 Jun;93(6):2255-62. doi: 10.1210/jc.2007-2188. Epub 2008 Mar 11.
4
Post-prandial alterations in LDL size and subclasses in patients with growth hormone deficiency.生长激素缺乏患者餐后低密度脂蛋白大小和亚类的变化
Growth Horm IGF Res. 2008 Jun;18(3):264-6. doi: 10.1016/j.ghir.2007.10.003. Epub 2007 Dec 3.
5
Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.生长激素缺乏患者短期替代治疗前后的致动脉粥样硬化脂蛋白表型及低密度脂蛋白大小和亚类
Eur J Endocrinol. 2007 Mar;156(3):361-7. doi: 10.1530/EJE-06-0652.
6
Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.2589例垂体功能减退性生长激素缺乏成人患者心血管风险的决定因素——一项KIMS数据库分析
Eur J Endocrinol. 2006 Jul;155(1):79-90. doi: 10.1530/eje.1.02179.
7
Low-density lipoprotein size and cardiovascular risk assessment.低密度脂蛋白大小与心血管风险评估。
QJM. 2006 Jan;99(1):1-14. doi: 10.1093/qjmed/hci154.
8
The metabolic syndrome--a new worldwide definition.代谢综合征——一个新的全球定义。
Lancet. 2005;366(9491):1059-62. doi: 10.1016/S0140-6736(05)67402-8.
9
Resistin is an inflammatory marker of atherosclerosis in humans.抵抗素是人类动脉粥样硬化的一种炎症标志物。
Circulation. 2005 Feb 22;111(7):932-9. doi: 10.1161/01.CIR.0000155620.10387.43. Epub 2005 Feb 14.
10
Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults.短期和长期给予重组人生长激素对生长激素缺乏成年人胃饥饿素和脂联素水平的不同影响。
Clin Endocrinol (Oxf). 2004 Jul;61(1):81-7. doi: 10.1111/j.1365-2265.2004.02067.x.